INOVIO PHARMACEUTICALS, INC. Increase (Decrease) in Deferred Rent Receivables (Deprecated 2012-01-31)
INOVIO PHARMACEUTICALS, INC. (INO) reported Increase (Decrease) in Deferred Rent Receivables (Deprecated 2012-01-31) of $215 for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRentReceivables · last filed 2012-05-09
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in deferred rent receivables (deprecated 2012-01-31) for the quarter ending 2012-03-31 was $215.00, a 98.44% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in deferred rent receivables (deprecated 2012-01-31) for the quarter ending 2011-12-31 was -$12.60K.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in deferred rent receivables (deprecated 2012-01-31) for the quarter ending 2011-09-30 was -$2.13K.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in deferred rent receivables (deprecated 2012-01-31) for the quarter ending 2011-06-30 was -$12.86K.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in deferred rent receivables (deprecated 2012-01-31) for fiscal 2011 was -$13.76K.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in deferred rent receivables (deprecated 2012-01-31) for fiscal 2010 was -$55.77K, a 142.57% decline from fiscal 2009.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in deferred rent receivables (deprecated 2012-01-31) for fiscal 2009 was $131.02K.
| Period end | Increase (Decrease) in Deferred Rent Receivables (Deprecated 2012-01-31) 3 month | Increase (Decrease) in Deferred Rent Receivables (Deprecated 2012-01-31) 6 month | Increase (Decrease) in Deferred Rent Receivables (Deprecated 2012-01-31) 9 month | Increase (Decrease) in Deferred Rent Receivables (Deprecated 2012-01-31) 12 month |
|---|---|---|---|---|
| 2012-03-31 | $215.00 10-Q · filed 2012-05-09 | -$12.38K derived: sum of 2 quarters · filed 2012-05-09 | -$14.51K derived: sum of 3 quarters · filed 2012-05-09 | -$27.37K derived: sum of 4 quarters · filed 2012-05-09 |
| 2011-12-31 | -$12.60K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-15 | -$14.72K derived: sum of 2 quarters · filed 2012-03-15 | -$27.59K derived: sum of 3 quarters · filed 2012-03-15 | -$13.76K 10-K · filed 2012-03-15 |
| 2011-09-30 | -$2.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | -$14.99K derived: sum of 2 quarters · filed 2011-11-07 | -$1.17K 10-Q · filed 2011-11-07 | -$18.61K derived: sum of 4 quarters · filed 2012-05-09 |
| 2011-06-30 | -$12.86K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-05 | $958.00 10-Q · filed 2011-08-05 | -$16.48K derived: sum of 3 quarters · filed 2012-05-09 | -$24.27K derived: sum of 4 quarters · filed 2012-05-09 |
| 2011-03-31 | $13.82K 10-Q · filed 2012-05-09 | -$3.62K derived: sum of 2 quarters · filed 2012-05-09 | -$11.41K derived: sum of 3 quarters · filed 2012-05-09 | |
| 2010-12-31 | -$17.44K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-15 | -$25.23K derived: sum of 2 quarters · filed 2012-03-15 | -$55.77K 10-K · filed 2012-03-15 | |
| 2010-09-30 | -$7.79K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | -$38.33K 10-Q · filed 2011-11-07 | ||
| 2010-06-30 | -$30.54K 10-Q · filed 2011-08-05 | |||
| 2009-12-31 | $131.02K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |